Science Market Update

UCSD Clinical Trial of New Treatment for Blood Cancers

Posted by Gloria Beverage on Thu, Jul 05, 2018

Researchers at the University of California San Diego School of Medicine are hopeful the combination of the experimental drug cirmtuzumab along with ibrutinub can halt the progression of chronic B-cell cancers. In an article published in the June 1 issue of Cell Stem Cell, researchers reported that treatment of 26 chronic leukemia patients with the experimental drug combination appeared to stop the disease’s progress.

Read More

Tags: 2018, SDVS, Biotechnology Vendor Showcase, UCSD, CA, San Diego, life sciecne, San diego Biotech, University of California San Diego, san diego research, Research Funding, laboratory equipment suppliers, Bioresearch product fair, Blood Cancer, cancer reserach

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News